0.4027
0.0000
(0.00%)
At close: January 23 at 7:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-959.5110
-1,615.6430
-1,806.0530
Investing Cash Flow
--
--
-10.9990
Financing Cash Flow
925.5810
903.1460
2,551.0300
End Cash Position
37.0800
21.4810
733.9780
Interest Paid Supplemental Data
5.4740
7.1920
7.4740
Capital Expenditure
--
--
-10.9990
Issuance of Capital Stock
--
--
2,675.9400
Repayment of Debt
-161.5880
-343.6110
-338.2580
Free Cash Flow
-959.5110
-1,615.6430
-1,817.0520
12/31/2022 - 3/3/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ONC.L Oncimmune Holdings plc
11.80
-5.60%
TCF.L Theracryf Plc
0.8750
0.00%
ENDV Endonovo Therapeutics, Inc.
0.0003
0.00%
TRX.L Tissue Regenix Group plc
59.00
0.00%
MLEC Moolec Science SA
0.7926
-5.71%
OKYO OKYO Pharma Limited
1.0500
+3.45%
POLB.L Poolbeg Pharma PLC
5.35
+13.83%
FUM.L Futura Medical plc
30.78
-0.97%
MEIP MEI Pharma, Inc.
2.8500
+2.15%
SNG.L Synairgen plc
2.1750
+17.73%